phenytoin
Generic: phenytoin
Labeler: american health packagingDrug Facts
Product Profile
Brand Name
phenytoin
Generic Name
phenytoin
Labeler
american health packaging
Dosage Form
SUSPENSION
Routes
Active Ingredients
phenytoin 125 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
60687-275
Product ID
60687-275_3f00559d-7f12-eadc-e063-6294a90a7962
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA040521
Listing Expiration
2026-12-31
Marketing Start
2019-01-10
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
60687275
Hyphenated Format
60687-275
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
phenytoin (source: ndc)
Generic Name
phenytoin (source: ndc)
Application Number
ANDA040521 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 125 mg/5mL
Packaging
- 5 TRAY in 1 CASE (60687-275-66) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-275-63) / 4 mL in 1 CUP, UNIT-DOSE (60687-275-62)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3f00559d-7f12-eadc-e063-6294a90a7962", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000191266", "N0000187064", "N0000187063", "N0000185607", "N0000191267", "N0000190118", "N0000185507"], "unii": ["6158TKW0C5"], "rxcui": ["1313112"], "spl_set_id": ["f9fe4c92-2761-4cb4-9cf3-7066e240e014"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_moa": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "5 TRAY in 1 CASE (60687-275-66) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-275-63) / 4 mL in 1 CUP, UNIT-DOSE (60687-275-62)", "package_ndc": "60687-275-66", "marketing_start_date": "20190110"}], "brand_name": "Phenytoin", "product_id": "60687-275_3f00559d-7f12-eadc-e063-6294a90a7962", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "60687-275", "generic_name": "Phenytoin", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin", "active_ingredients": [{"name": "PHENYTOIN", "strength": "125 mg/5mL"}], "application_number": "ANDA040521", "marketing_category": "ANDA", "marketing_start_date": "20190110", "listing_expiration_date": "20261231"}